Celero Systems is developing an ingestible system that monitors cardiac and respiratory vital signs to detect opioid overdose in real-time. This technology provides timely medication intervention without the need for wires or wearables, addressing the critical issue of opioid-related fatalities.
Funding
$6.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Opioid overdose is a significant public health crisis, often resulting in fatalities due to delayed detection and intervention. Current monitoring methods rely on external devices, such as wires and wearables, which can be cumbersome, uncomfortable, and may not provide real-time alerts. This lack of discreet and timely monitoring hinders effective intervention and contributes to the high rate of opioid-related deaths.
Solution
Celero Systems is developing an ingestible digital health platform designed to monitor cardiac and respiratory vital signs for the early detection of opioid overdose. The system aims to provide real-time data and medication intervention without the need for external wires or wearable devices. By safely and discreetly monitoring vital signs from within the body, the platform enables timely alerts and intervention, potentially preventing fatal outcomes associated with opioid overdose. The "one pill" approach focuses on delivering data and medication only when needed, streamlining the intervention process.
Target Audience
The primary target audience includes individuals at high risk of opioid overdose, healthcare providers managing patients on opioid therapy, and emergency medical services personnel.
Features
- Ingestible sensor technology for continuous monitoring of cardiac and respiratory function.
- Real-time detection algorithms to identify signs of opioid overdose.
- Wireless data transmission to a secure monitoring platform.
- Automated alerts to healthcare providers or emergency services upon detection of an overdose event.
- Potential for integrated drug delivery system for immediate medication intervention.
- Discreet and non-invasive monitoring solution.